CipherOx CRI Tablet

FDA 510(k) K213255 · Flashback Technologies, Inc.

Substantially Equivalent

510(k) numberK213255

Submission

Device name
CipherOx CRI Tablet
Applicant
Flashback Technologies, Inc.
Westfield, NJ, US
Received
September 30, 2021
Decision date
June 17, 2022
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
PPW – Adjunctive Cardiovascular Status Indicator
Device class
Class II (moderate risk)
Regulation
21 CFR 870.2200
Specialty
Cardiovascular

The adjunctive cardiovascular status indicator is a prescription device based on sensor technology for the measurement of a physical parameter(s). This device is intended for adjunctive use with other physical vital sign parameters and patient information and is not intended to independently direct therapy.

Other 510(k)s with product code PPW

510(k)DeviceApplicantDecision
K254066Etiometry PlatformPPW · Special Etiometry, Inc.04/03/2026SE
K252204prolaio eVO2peak Module (Version 1.0)PPW · Traditional Prolaio, Inc.12/16/2025SE
K241479Etiometry Platform (DAV 5.4 RAE 9.2)PPW · Traditional Etiometry, Inc.02/12/2025SE
K223578T3 Platform softwarePPW · Traditional Etiometry, Inc.07/07/2023SE
K213230T3 Platform SoftwarePPW · Traditional Etiometry, Inc.06/22/2022SE
K173929CipherOx CRI M1PPW · Traditional Flashback Technologies, Inc.07/24/2018SE

More from Flashback Technologies, Inc.

510(k)DeviceDecision
K173929CipherOx CRI M1PPW · Traditional 07/24/2018SE

Questions and answers

When was CipherOx CRI Tablet cleared by the FDA?

CipherOx CRI Tablet (K213255) received a 510(k) decision of Substantially Equivalent on June 17, 2022, 260 days after the submission was received.

What is the product code of K213255?

The FDA product code is PPW – Adjunctive Cardiovascular Status Indicator, a Class II (moderate risk) device regulated under 21 CFR 870.2200.